SVI
LSBPW

Strategic Vision Investment’s LakeShore Biopharma Warrants LSBPW Stock Holding History

Strategic Vision Investment’s Portfolio LSBPW Stock Details LSBPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-38,857
Closed -$1.48K – 26
2023
Q4 		$1.48K Hold
38,857
– – ﹤0.01% 11
2023
Q3 		$1.6K Hold
38,857
– – ﹤0.01% 10
2023
Q2 		$1.83K Hold
38,857
– – ﹤0.01% 15
2023
Q1 		$6.05K Buy
+38,857
New +$5.89K ﹤0.01% 24

Other funds holding LSBPW

AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
VAM
Valliance Asset Management Central, Hong Kong $122M AUM 362.1% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
BP
BFAM Partners Northpoint, Hong Kong, Hong Kong $44K AUM 8.69% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return
QGA
Q Global Advisors Fort Worth, Texas $113M AUM 20.91% 1-Year Est. Return

Strategic Vision Investment's LSBPW Position: Q1 2024 in Review

Strategic Vision Investment sold out of LakeShore Biopharma Warrants (LSBPW) in Q1 2024, closing a stake of 38,857 shares — an estimated $1.48K sold.

Strategic Vision Investment first reported a position in LSBPW in Q1 2023 and held it in 4 quarters. The position peaked at $6.05K in Q1 2023. 25 funds tracked by Wall St. Rank hold LSBPW as of Q1 2024.

  • Strategic Vision Investment reported no remaining LakeShore Biopharma Warrants position as of Q1 2024 after selling out during the quarter.
  • Strategic Vision Investment sold 38,857 LakeShore Biopharma Warrants shares in Q1 2024, an estimated $1.48K.
  • Strategic Vision Investment first reported a position in LakeShore Biopharma Warrants in Q1 2023 and held it in 4 quarters.
  • Strategic Vision Investment's LakeShore Biopharma Warrants position peaked at $6.05K in Q1 2023.
  • 25 funds tracked by Wall St. Rank held LakeShore Biopharma Warrants as of Q1 2024.

Based on Strategic Vision Investment's 13F filing for Q1 2024, filed 13 May 2024.